IP Verse

Boehringer Ingelheim Vetmedica, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Boehringer Ingelheim Vetmedica, Inc. opposed by its competitors

Patent:
EP3035958
Grant Date:
Oct 26, 2022
Title:
Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine
Oppositions:
2
Patent:
EP2275132
Grant Date:
Mar 3, 2021
Title:
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them
Oppositions:
3
Patent:
EP3127551
Grant Date:
Jul 29, 2020
Title:
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs
Oppositions:
3
Patent:
EP3320919
Grant Date:
May 27, 2020
Title:
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
Oppositions:
2
Patent:
EP2460820
Grant Date:
Jun 19, 2019
Title:
Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
Oppositions:
3
Patent:
EP2481420
Grant Date:
Feb 20, 2019
Title:
Single Dose Anti-Pcv2 Pig Vaccine
Oppositions:
2
Patent:
EP2931741
Grant Date:
Jul 25, 2018
Title:
Porcine Parvovirus 5A, Methods Of Use And Vaccine
Oppositions:
1
Patent:
EP2992897
Grant Date:
Jul 4, 2018
Title:
Immunogenic Compositions Comprising Lawsonia Intercellularis
Oppositions:
2
Patent:
EP1968630
Grant Date:
Jan 24, 2018
Title:
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
Oppositions:
3
Patent:
EP2460817
Grant Date:
Mar 29, 2017
Title:
Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
Oppositions:
1

Competitors of Boehringer Ingelheim Vetmedica, Inc.

CEVA SANTE ANIMALE

LABORATORIOS HIPRA, S.A.

ELANCO US INC.

Want to track Boehringer Ingelheim Vetmedica, Inc.?

Feel free to send us a message here and we will get back to you